Impact of pharmacological interventions on intrapulmonary shunt during one-lung ventilation in adult thoracic surgery: a systematic review and component network meta-analysis.


Journal

British journal of anaesthesia
ISSN: 1471-6771
Titre abrégé: Br J Anaesth
Pays: England
ID NLM: 0372541

Informations de publication

Date de publication:
01 2023
Historique:
received: 24 05 2022
revised: 05 08 2022
accepted: 24 08 2022
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 23 3 2023
Statut: ppublish

Résumé

Intrapulmonary shunt is a major determinant of oxygenation in thoracic surgery under one-lung ventilation. We reviewed the effects of available treatments on shunt, Pao Online databases were searched for RCTs comparing pharmacological interventions and intrapulmonary shunt in thoracic surgery under one-lung ventilation up to March 30, 2022. Random-effects (component) network meta-analysis compared 24 treatments and 19 treatment components. The Confidence in Network Meta-Analysis (CINeMA) framework assessed evidence certainty. The primary outcome was intrapulmonary shunt fraction during one-lung ventilation. A total of 55 RCTs were eligible for systematic review (2788 participants). The addition of N Adding N PROSPERO CRD42022310313.

Sections du résumé

BACKGROUND
Intrapulmonary shunt is a major determinant of oxygenation in thoracic surgery under one-lung ventilation. We reviewed the effects of available treatments on shunt, Pao
METHODS
Online databases were searched for RCTs comparing pharmacological interventions and intrapulmonary shunt in thoracic surgery under one-lung ventilation up to March 30, 2022. Random-effects (component) network meta-analysis compared 24 treatments and 19 treatment components. The Confidence in Network Meta-Analysis (CINeMA) framework assessed evidence certainty. The primary outcome was intrapulmonary shunt fraction during one-lung ventilation.
RESULTS
A total of 55 RCTs were eligible for systematic review (2788 participants). The addition of N
CONCLUSIONS
Adding N
SYSTEMATIC REVIEW PROTOCOL
PROSPERO CRD42022310313.

Identifiants

pubmed: 36939497
pii: S0007-0912(22)00516-5
doi: 10.1016/j.bja.2022.08.039
pii:
doi:

Substances chimiques

Almitrine 9A1222NBG4
Iloprost JED5K35YGL
Propofol YI7VU623SF

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e92-e105

Informations de copyright

Copyright © 2022 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of interest AH has received speaker fees from Medtronic International (Sàrl, Tolochenaz, Switzerland) regarding an unrelated topic. The other authors have no direct or indirect conflict of interest to report.

Auteurs

Raoul Schorer (R)

Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic address: raoul.schorer@hcuge.ch.

Anna-Luna Dombret (AL)

Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.

Andres Hagerman (A)

Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.

Benoît Bédat (B)

Division of Thoracic and Endocrine Surgery, Geneva University Hospitals, Geneva, Switzerland.

Alessandro Putzu (A)

Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH